Evidence-Based GLP-1 Information for Patients & Providers

About GLP-1 Authority

We are an independent, evidence-based resource dedicated to providing accurate, up-to-date information about GLP-1 receptor agonists for patients, caregivers, and healthcare providers.

Our Purpose

Mission & Editorial Standards

GLP-1 Authority was founded to cut through the noise surrounding GLP-1 medications. With billions of dollars in marketing from pharmaceutical companies and countless unverified claims online, patients deserve a trustworthy, independent source of information.

Our team of physicians, pharmacists, and medical writers synthesizes the latest clinical trial data, FDA communications, and peer-reviewed research into clear, actionable guidance — so you can make informed decisions about GLP-1 therapy.

1,200+
Studies Reviewed
8
FDA-Approved GLP-1 Drugs
4
Board-Certified Reviewers
Monthly
Content Updates
GLP-1 Authority research team
How We Work

Our Editorial Standards

Peer-Reviewed Sources

All clinical claims are sourced from peer-reviewed journals including NEJM, JAMA, The Lancet, and Diabetes Care.

Medical Review

Every article is reviewed by at least one licensed physician or pharmacist before publication.

Regular Updates

Content is reviewed and updated monthly to reflect the latest FDA approvals, trial data, and clinical guidelines.

Transparent Disclosures

All affiliate relationships and potential conflicts of interest are clearly disclosed on every page.

Expert Oversight

Medical Review Board

All content is reviewed by board-certified physicians and pharmacists with expertise in GLP-1 therapy

Dr. Sarah M. Chen, MD, PhD

Dr. Sarah M. Chen, MD, PhD

Medical Director & Lead Reviewer

Endocrinology, Metabolic Medicine

Dr. James K. Okafor, MD

Dr. James K. Okafor, MD

Clinical Research Editor

Obesity Medicine, Internal Medicine

Dr. Priya R. Nair, PharmD

Dr. Priya R. Nair, PharmD

Pharmacology Reviewer

Clinical Pharmacology, Drug Safety

Dr. Marcus T. Webb, MD

Dr. Marcus T. Webb, MD

Cardiovascular Research Editor

Cardiology, Cardiometabolic Risk

Affiliate Disclosure

GLP-1 Authority participates in affiliate marketing programs. When you click on links to telehealth platforms, pharmacies, or other services and make a purchase, we may earn a commission at no additional cost to you. This helps fund our independent research and editorial operations. Our editorial content is never influenced by affiliate relationships — all recommendations are based solely on clinical evidence and patient outcomes data.

Questions or Corrections?

If you spot an error, have a question about our methodology, or want to suggest a topic, we'd love to hear from you.

Contact Our Team